Dorina Dobi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells.
Journal: Glycoconjugate journal
Published: June 23, 2025
GM1 oligosaccharide-mediated rescue in GBA-linked Parkinson's disease via modulation of lysosomal and mitochondrial dysfunctions.
Journal: Glycoconjugate journal
Published: April 30, 2025
Effect of CFTR modulators Elexacaftor/Tezacaftor/Ivacaftor on lipid metabolism in human bronchial epithelial cells.
Journal: Glycoconjugate journal
Published: November 14, 2024
Anti-inflammatory activity of Pseudomonas aeruginosa DEV phage in cystic fibrosis models.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 23, 2024
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS).
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 28, 2024
Cross-talk between CFTR and sphingolipids in cystic fibrosis.
Journal: FEBS open bio
Published: April 07, 2023
Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System.
Journal: Advances in neurobiology
Published: October 18, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026